Term ends Dec 27, 2027
Statutory term ends Nov 6, 2027
Base term plus 51 days of PTA
Today
20y-from-earliest-nonprovisional
Expires in 15 months
2007
2027
Clock starts
Nov 6, 2007
Nov 6, 2007
Granted
Sep 27, 2011
Sep 27, 2011
Term ends
Dec 27, 2027
Dec 27, 2027
base term
patent term adjustment
fee events
Computed Sep 1, 2026 · countdowns run from that date · how we know
51
Days of PTA
34
Applications in this family
This patent's term runs 51 days past the statutory base term on prosecution delay. All three maintenance fees are paid, so nothing but the term itself will end it. Confidence: High. from the record
How this date was computed
Every step shows its rule, its input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20y-from-earliest-nonprovisional | Clock starts Nov 6, 2007 | Nov 6, 2027 | High |
| Continuity chain | Every parent in the chain resolved | no change | High |
| Patent term adjustment | +51 days, USPTO PTA record | Dec 27, 2027 | High |
| Terminal disclaimer cap | None on record | no cap applied | High |
| Patent term extension | None on file | no change | High |
| Fee events | 3 of 3 maintenance fees paid | in-force | High |
| Computed term end | The steps above, in order | Dec 27, 2027 | High |
The computation, verbatim
base=20y-from-earliest-nonprovisional: 2007-11-06+20y | =2027-11-06 | PTA+51d=2027-12-27 | PTE:none | TD:none | paid 4yr@2015-03-27,8yr@2019-03-27,12yr@2023-03-27 | status=in-force@2027-12-27
This family
| Application 60/857,440 | pending | not computed |
| Application 60/910,625 | pending | not computed |
| Application 60/910,618 | pending | not computed |
| Application 11/923,357 | abandoned | not computed |
| US 9,392,935 | in-force | Mar 2035 |
| US 8,025,656 | this patent | Dec 2027 |
| Application PCT/US2007/083833 | pending | not computed |
| Application PCT/US2007/083982 | pending | not computed |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 14, 2008 reel/frame not recorded | Gruber, William Harwick; Adams, Ronald David; Flaherty, J. Christopher | Interlace Medical, Inc. | Assignment of Assignor's Interest |
| Feb 18, 2011 reel/frame not recorded | Interlace Medical, Inc. | Hologic, Inc. | Assignment of Assignor's Interest |
| Aug 1, 2012 reel/frame not recorded | Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated; Hologic, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Goldman Sachs Bank USA | Security Agreement |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Security Interest Release Reel/Frame 028810/0745 |
| Jun 4, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Security Interest Release Reel/Frame 028810/0745 |
| Aug 7, 2015 Reel 36307, frame 199 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Bank of America, N.A., as Collateral Agent | Security Agreement |
| Aug 7, 2015 reel/frame not recorded | Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Hologic, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Bank of America, N.A., as Collateral Agent | Security Agreement |
Free plan: 3 watched companies. Pro: unlimited.
alerts on grants, lapses, transfers
Is this your company? Verify this record
What's changing
Dec 2027
Term ends. No further fees fall due before then
Note
The 51 days of PTA are read from the USPTO record, not recalculated by us
Citations
75
later US patents cite this one
That is top 5% of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: base rule, PTA, PTE, disclaimer caps, fee overlay, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.